The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathologic Characteristics of T-cell Non-Hodgkin's Lymphoma: A Single Institution Experience

Ko, Ock-Bae;Lee, Dae-Ho;Kim, Sang-We;Lee, Jung-Shin;Kim, Shin;Huh, Joo-ryung;Suh, Cheol-won

  • Published : 20090600
⟨ Previous Next ⟩

Abstract

Background/Aims: Although the incidence of T-cell non-Hodgkin’'s lymphoma (NHL) is higher in Far East Asia than in Western countries, its incidence and clinical course in Korea are not well-defined. Therefore, we assessed the relative frequency and clinical features of T-cell NHL in Korea. Methods: We performed a retrospetcive analysis of 586 patients with NHL. Results: 101 (17.2%) had T-cell NHL. The most frequent subtypes of T-cell NHL were extranodal NK/T-cell lymphoma, nasal type (NASAL), peripheral T-cell lymphoma, unspecified type (PTCL-U), and anaplastic large cell lymphoma, T/null cell, primary systemic type (ALCL). The seven pathological subtypes could be classified into three prognostic subgroups. When patients with the three most frequent subtypes were grouped together, their survival was reflected in the International Prognostic Index (IPI) scores. Univariate analysis of IPI elements and other clinical features showed that clinical stage and extranodal sites were significant predictors of survival. Cox multivariate analysis showed that the number of extranodal sites was the only independent prognostic indicator. Conclusions: The relative frequency of T-cell NHL seems to be decreasing in Korea, although NASAL remains frequent. Korean patients with ALCL appear to have an unfavorable prognosis. Large-scale studies are warranted for Korean patients with T-cell NHL.

Keywords

References

  1. American Cancer Society. Cancer facts and figures [Internet]. Cited 2008. Available from: www.cancer.org
  2. Muller A, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1-12 https://doi.org/10.1007/s00277-004-0939-7
  3. IARC. Cancer incidence, mortality and prevalence worldwide, version 1.0 IARC Cancer Base No.5 [Internet]. Cited 2001. Available from: http://www-dep.iarc.fr/globocan.htm
  4. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictvie model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994 https://doi.org/10.1056/NEJM199309303291402
  5. Ko YJ, Kim CW, Park CS, et al. Classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998;83:806-812 https://doi.org/10.1002/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.0.CO;2-V
  6. Mok TS, Steinberg J, Chan AT, et al. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma. Cancer 1998;82:2439-2448 https://doi.org/10.1002/(SICI)1097-0142(19980615)82:12<2439::AID-CNCR19>3.0.CO;2-Q
  7. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-111 https://doi.org/10.1097/00000478-199601000-00012
  8. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918
  9. Rudiger T, Weisenbruger DD, Anderson JR, et al. Peripheral Tcell lymphoma (excluding anaplastic large cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140-149 https://doi.org/10.1093/annonc/mdf033
  10. Kim HT, Im YH, Suh CI, et al. Malignant lymphomas in Korea. J Korean Cancer Assoc 1992;24:92-101
  11. Lopez-Guillermo A, Colomo L, jimenez M, et al. Diffuse lagrge Bcell lymphoma: clinical and biological characterization and outcome according to the nodal and extranodal primary origin. J Clin Oncol 2005;23:2797-2804 https://doi.org/10.1200/JCO.2005.07.155
  12. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clincal Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86 https://doi.org/10.1046/j.1365-2559.2000.00895.x
  13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53 https://doi.org/10.2307/2281868
  14. Mantel N. Evaluation of survival data and two new rank test order statistics arising in tis consideration. Cancer Chemother Rep 1966;50:163-170
  15. Cox D. Regression models and life-tables. J R Stat Soc 1972;34
  16. Rizvi MA, Evens AM, Tallman MS, Nelsoon BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood 2006;107:1255-1264 https://doi.org/10.1182/blood-2005-03-1306
  17. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol 1983;14:745-772 https://doi.org/10.1016/S0046-8177(83)80299-8
  18. Ho FC, Todd D, Loke SL, Ng RP, Khoo RK. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients: retrospective study covering an eight-year period. Int J Cancer 1984;34:143-148 https://doi.org/10.1002/ijc.2910340202
  19. The T- and B-cell Malignancy Group. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adutl T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. Jpn J Clin Oncol 1985;15:517-535
  20. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG). A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. Jpn J Clin Oncol 1985;15:645-651
  21. Aozasa K, Tsujimoto M, Sakurai M, et al. Non-Hodgkin's lymphomas in Osaka, Japan. Eur J Cancer Clin Oncol 1985;21:487-492 https://doi.org/10.1016/0277-5379(85)90042-2
  22. Newton R, Ferlay J, Beral V, Devesa S. The epidemiology of non-Hodgkin''s lymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997;72:923-930 https://doi.org/10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R
  23. Anderson JR, Armitage JO, Weisenbruger DD. Epidemiology of the non-Hodgkin''s lymphomas: distrubtions of the major subtypes differ by geographic locations. Non-Hodgkin''s Lymphoma Classification Project. Ann Oncol 1998;9:717-720 https://doi.org/10.1023/A:1008265532487
  24. National Cancer Center, National Cancer Registry of Korea [internet]. National Cancer center c2008. cited 2008 Oct 1. Available from: http://www.ncc.re.kr
  25. Kang YK, Kim BS, Kim TW, et al. Clinicopathologic characteristics of Korean non-Hodgkin's lymphomas based on REAL classification. J Korean Cancer Assoc 1999;31:641-652
  26. Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinocopathologcial findings and outcome. Blood 1999;93:2697-2706
  27. Gascoyne RD, Aoun P, chhanabhai M, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999;93:3913-3921
  28. Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semi Radiat Oncol 1995;5:281-300 https://doi.org/10.1016/S1053-4296(05)80027-X
  29. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas: part I. gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-737 https://doi.org/10.1023/A:1008282818705
  30. Zucca E, Conconi A, Cavalli F. Treatment of extranodal lymphomas. Best pract Res Clin Haematol 2002;15:533-547 https://doi.org/10.1053/beha.2002.0218
  31. Shih LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hematol Oncol Clin North Am 1991;5:983-1001
  32. Greiner TC, Medeiros LJ, Jaffe ES. Non-Hodgkin's lymphoma. Cancer 1995;75(1 Suppl):370-380 https://doi.org/10.1002/1097-0142(19950101)75:1+<370::AID-CNCR2820751319>3.0.CO;2-Q

Cited by

  1. Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification vol.85, pp.10, 2009, https://doi.org/10.1002/ajh.21824
  2. Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukaemia/lymphoma cases vol.15, pp.6, 2009, https://doi.org/10.1179/102453310x12719010991902
  3. Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma vol.22, pp.7, 2011, https://doi.org/10.1093/annonc/mdq645
  4. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution vol.6, pp.1, 2009, https://doi.org/10.1186/1746-1596-6-77
  5. Analysis of 142 Northern Chinese Patients With Peripheral T/NK-Cell Lymphomas : Subtype Distribution, Clinicopathologic Features, and Prognosis vol.138, pp.3, 2009, https://doi.org/10.1309/ajcpwkj3gpfrt7ga
  6. Primary Extra Nodal Non Hodgkin Lymphoma: A 5 Year Retrospective Analysis vol.13, pp.10, 2012, https://doi.org/10.7314/apjcp.2012.13.10.4889
  7. Comparison Between Presence of Epstein Barr Virus in Nodal and Extra Nodal Diffuse Large B Cell Lymphoma of Head and Neck, an Iranian Experience vol.14, pp.12, 2009, https://doi.org/10.5812/ircmj.1302
  8. Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma vol.9, pp.None, 2009, https://doi.org/10.2147/ott.s93687
  9. Peripheral T-cell Lymphoma Presenting with Chylothorax vol.92, pp.1, 2017, https://doi.org/10.3904/kjm.2017.92.1.74
  10. Pattern of T-cell Non-Hodgkin's Lymphoma in a Tertiary Care Center in North East India vol.40, pp.3, 2019, https://doi.org/10.4103/ijmpo.ijmpo_74_18